Biopharmaceutical Contract Manufacturing Market to Surpass US$ 100 Billion by 2031 [Yahoo! Finance]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance
Advanced technologies like continuous manufacturing, AI, and PAT enhance production efficiency. The oncology segment dominates, driven by personalized treatments such as CAR-T therapies. Biopharmaceutical Contract Manufacturing Market Dublin, Dec. 11, 2025 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Contract Manufacturing Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Source, Application, Therapeutic Area, and Geography" has been added to ResearchAndMarkets.com's offering. The biopharmaceutical contract manufacturing market is projected to expand from US$ 40.99 billion in 2024 to US$ 101.05 billion by 2031, achieving a CAGR of 13.8% between 2025 and 2031. This growth is largely fueled by the increasing demand for biologics, along with the necessity for cost efficiency and flexibility. However, economic constraints pose challenges to market expansion. Innovations in manufacturing, such as monoclonal a
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Novartis (NVS) Enters $1.7 Billion Development Deal, Says Report [Yahoo! Finance]Yahoo! Finance
- Novartis breaks ground on flagship manufacturing hub in North Carolina [Yahoo! Finance]Yahoo! Finance
- Novartis breaks ground on flagship manufacturing hub in North CarolinaGlobeNewswire
- Drugmaker Novartis begins work on Research Triangle expansion [Yahoo! Finance]Yahoo! Finance
- Sen-Jam Pharmaceutical Secures Major Strategic Partnership with TASK Clinical to Fund Two-Thirds of Phase 3 Trial for SJP-001 [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 10/28/25 - Miss
NVS
Sec Filings
- 11/25/25 - Form 6-K
- 11/20/25 - Form 6-K
- 11/5/25 - Form 6-K
- NVS's page on the SEC website